YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS

Sell AI employees under your own brand.

Agentic AI Comparison:
Google Opal vs Tilda Bio AI

Google Opal - AI toolvsTilda Bio AI logo

Introduction

Google Opal is an experimental visual mini-app builder scheduled to turn off on November 17, 2026. Tilda builds AI teammates for clinical-trial document and site operations. Ratings are subjective editorial opinions for each product’s stated purpose, not measured benchmarks.

Overview

Google Opal

Google Opal is an experimental visual mini-app builder scheduled to turn off on November 17, 2026. Opal chains prompts, model calls and tools into shareable workflows. Google says interactive workflows will stop on November 17; saved files remain in the user’s Google Drive.

Tilda Bio AI

Tilda builds AI teammates for clinical-trial document and site operations. Trial Master File teammates classify, check and file documents, request corrections and escalate exceptions. Site and Study Management covers feasibility, startup documents, protocol amendments and credentials. Study Monitoring and Finance & Payments are listed as coming soon.

Editorial ratings · 1–10, higher is better

These scores express our judgement of the cited product facts. They are not measured performance benchmarks. Each product is assessed for its stated purpose; a higher score does not make different workflows interchangeable.

Evidence gaps lower confidence and affect the relevant judgement. Unknown pricing does not mean free access. Research prototypes and retired products retain their historical scope, with adoption ratings reflecting current access.

Ratings assessed: 2026-11-08. Source verification dates may differ.

Documented capability: How useful and complete is the documented workflow for the product's stated purpose?

  • 1–2: No usable current workflow established, or only an unsupported promise.
  • 3–4: Historical, experimental or very limited workflow; substantial delivery gaps.
  • 5–6: Concrete but narrow workflow, or promising research requiring specialist review.
  • 7–8: Substantial documented end-to-end workflow with useful controls or customization.
  • 9–10: Exceptionally complete documented scope and controls; reserve 10 for unusually strong evidence.

Ease of adoption: Can the intended user obtain and set up a usable product today?

  • 1–2: Discontinued, unavailable, waitlisted, or no usable deployment path verified.
  • 3–4: Archived software, restricted research/preorder access or uncertain current service access.
  • 5–6: Developer-managed setup, significant configuration or sales-led implementation.
  • 7–8: Active accessible product with manageable setup for its intended user.
  • 9–10: Straightforward self-service access and setup, with unusually few adoption obstacles.

Value and cost clarity: How attractive and understandable is the cost model for the documented use?

  • 1–2: No current purchasable or usable offer; historical prices cannot support a purchase.
  • 3–4: Material price, entitlement, license or availability uncertainty limits budgeting.
  • 5–6: Plausible value with custom pricing, significant setup costs or incomplete selected-plan terms.
  • 7–8: Useful scope with clear entry pricing/allowances or accessible source, while accounting for running costs.
  • 9–10: Exceptionally accessible and clear cost model for substantial useful scope; never assume free compute.

Integration options: How useful and extensible are the verified user-facing connections for the intended workflow?

  • 1–2: No current user-facing connection verified, or former connections are unavailable.
  • 3–4: Inputs/exports or one focused connection; internal dependencies are not native connectors.
  • 5–6: Useful API, configurable tools or several relevant connections, with limited verified breadth.
  • 7–8: Broad relevant connections or an extensible documented API/MCP/tool ecosystem.
  • 9–10: Extensive documented ecosystem with multiple connection mechanisms and strong task relevance.

Metrics Comparison

Documented capability

Google Opal: 6/10

Evidence confidence: high

Opal chains prompts, model calls and tools into shareable workflows. Google says interactive workflows will stop on November 17; saved files remain in the user’s Google Drive.

Tilda Bio AI: 8/10

Evidence confidence: high

Trial Master File teammates classify, check and file documents, request corrections and escalate exceptions. Site and Study Management covers feasibility, startup documents, protocol amendments and credentials. Study Monitoring and Finance & Payments are listed as coming soon.

The scores judge completeness for each stated purpose; different workflows are not interchangeable.

Ease of adoption

Google Opal: 2/10

Evidence confidence: high

Existing users should save their prompts before shutdown. Workflows will not automatically migrate to Gemini skills or AI Studio.

Tilda Bio AI: 6/10

Evidence confidence: high

Trial teams configure protocols, standard operating procedures and system access. Staff supervise exceptions and retain clinical and operational decisions.

Access, setup and human responsibilities matter alongside features.

Value and cost clarity

Google Opal: 2/10

Evidence confidence: high

The approaching shutdown limits the value of building new dependencies on Opal, regardless of its experimental access price.

Tilda Bio AI: 5/10

Evidence confidence: high

Deployment is sales-led; request a quote for the study scope, implementation and ongoing usage. The free educational masterclass is separate from the software.

Compare the full cost of your intended workflow, including external services and implementation.

Integration options

Google Opal: 3/10

Evidence confidence: high

Google Drive stores workflow files, and mini-apps can use supported generation and search tools. These hosted workflows will stop running after shutdown.

Tilda Bio AI: 5/10

Evidence confidence: high

Connections are configured around the customer’s eClinical systems. Confirm compatibility with your document repository and study tools during implementation.

Choose the connections your workflow needs, rather than counting partner logos.

Conclusions

Avoid starting a long-term workflow on Opal now. Preserve existing prompts and evaluate Gemini skills or AI Studio for a manually rebuilt workflow.

Choose Tilda for clinical operations teams seeking document follow-up and site coordination within their existing study processes.

YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS

Sell AI employees under your own brand.

Give businesses AI teams that own ongoing roles. Set your pricing, delegate routine coordination and build a recurring service.